Bristol-Myers Squibb Company (BMY)
Update on Phase 3 Librexia ACS Trial
Update on Phase 3 Librexia ACS Trial
Merck to Acquire Cidara Therapeutics, Inc., Diversifying Its Portfolio to Include Late-Phase Antiviral Agent
Teleflex - Teleflex to Present at the Jefferies Global Healthcare Conference in London
Teleflex to Present at the Jefferies Global Healthcare Conference in London
embecta Announces Major New Commitment to Direct Relief on World Diabetes Day
Avadel Receives Unsolicited Proposal from Lundbeck
Riverstone Holdings Limited - Announcement
Notice Of Record Date
uniQure N.V. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - QURE
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm